HER2-IN-9
Product Specifications
Target
Others, EGFR
Related Pathways
JAK/STAT signaling, Tyrosine Kinase/Adaptors, Others, Angiogenesis
Bioactivity
HER2-IN-9, an orally active HER2 inhibitor (IC50: 0.03 μM), inhibits the proliferation and migration of HER-2-positive breast cancer cells and is employed in breast cancer research.
Molecular Formula
C19H14BrF3N2O
Molecular Weight
423.23
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2121740-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Runt Related Transcription Factor 1 (RUNX1)
Sign In for Pricing
View Details MBS2121740-02 0.2 mL
Cy3-Linked Polyclonal Antibody to Runt Related Transcription Factor 1 (RUNX1)
Sign In for Pricing
View Details MBS2121740-03 0.5 mL
Cy3-Linked Polyclonal Antibody to Runt Related Transcription Factor 1 (RUNX1)
Sign In for Pricing
View Details MBS2121740-04 1 mL
Cy3-Linked Polyclonal Antibody to Runt Related Transcription Factor 1 (RUNX1)
Sign In for Pricing
View Details MBS2121740-05 5 mL
Cy3-Linked Polyclonal Antibody to Runt Related Transcription Factor 1 (RUNX1)
Sign In for Pricing
View Details MBS2121740-06 5x 5 mL
Cy3-Linked Polyclonal Antibody to Runt Related Transcription Factor 1 (RUNX1)
Sign In for Pricing
View Details